drugset / Trial / NCT00514852

Safety and Efficacy of an Artificial Tear for the Treatment of Dry Eye

NCT00514852

Completed 316 enrolled Allergan
RandomizedParallel-groupDouble-blindTreatment

Summary

The efficacy, safety and acceptability of a new artificial tear in subjects with dry eye will be compared to a currently-available artificial tear

Timeline

Start
2007-10
Primary completion
2008-01
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Carboxymethylcellulose Other / unclassified Other
Subject Glycerin Other / unclassified Other

Indications